Tumour necrosis factor-α levels in hepatitis B virus-related chronic active hepatitis and liver cirrhosis and its relationship to Knodell and Child-Pugh scores

International Journal of Clinical Practice

Volumn 60, Issue 9, 2006, Pages 1075-1079

  Kiki, Ilhami ^a   Yilmaz, O ^a   Erdem, F ^a   Gundogdu, M ^a   Demircan, B ^a   Bilici, M ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

Child Pugh score; Chronic active hepatitis B; Hepatitis activity index; Liver cirrhosis; TNF

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC ACTIVE HEPATITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; LIVER CIRRHOSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33747168761     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.00936.x     Document Type: Article

References (31)

1. Nair S, Perillo RP. Hepatitis B and D. In: Zakim D, Boyer TD, eds. Hepatology. A Textbook of Liver Disease, Vol. 2, 4th edn. Philadelphia: Saunders Co, 2003: 959-1016.
2. Warren JS, Ward PA. The inflammatory response. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U, eds. Williams Hematology, 6th edn. New York: Mcgraw Hill Co, 2001: 67-75.
3. Lehrer RI, Ganz T. Biochemistry and function of monocytes macrophages. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U, eds. Williams Hematology, 6th edn. New York: Mcgraw Hill Co, 2001: 865-76.
4. Wickremasinghe RG, Hoffbrand AV. Biochemical and genetic control of apoptosis: Relevance to normal hematopoiesis and hematological malignancies. Blood 1999; 93: 3587-600.
5. Shadduk RK. Aplastic anemia. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U, eds. Williams Hematology, 6th edn. New York: Mcgraw Hill Co, 2001: 375-89.
6. Lau JY, Xie X, Lai MM, Wu PC. Apoptosis and viral hepatitis. Semin Liver Dis 1998; 18: 169-76.
7. Dienstag JL, Isselbacher KJ. Chronic hepatitis. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, eds. Harrison's Principles of Internal Medicine, 16th edn, Part: XII, Ch: 287, New York: Mcgraw Hill Co, 2005: 1844-55.
8. Ghany M, Hoofnagle JH. Approach to the patient with liver disease. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, eds. Harrison's Principles of Internal Medicine, 16th edn, Part: XII, Ch: 287, New York: Mcgraw Hill Co, 2005: 1808-13.
9. Tilg H. Cytokines and liver diseases. Can J Gastroenterol 2001; 15: 661-8.
10. Monsalve-De Castillo F, Romero TA, Estevez J et al. Concentrations of cytokines, soluble interleukin-2 receptor, and soluble CD30 in sera of patients with hepatitis B virus infection during acute and convalescent phases. Clin Diagn Lab Immunol 2002; 9: 1372-5.
11. Crawford JM. Liver cirrhosis. In: MacSween RNM, Burt AD, Portmann BC, Ishak KG, Scheuer PJ, Anthony PP, eds. Pathology of the Liver, New York: Churchill Livingstone, 2002: 575-619.
12. Torre D, Zeroli C, Giola M et al. Serum levels of interleukin-1 alpha, interleukin-1 beta, interleukin-6, and tumor necrosis factor in patients with acute viral hepatitis. Clin Infect Dis 1994; 18: 194-8.
13. Sekiyama KD, Yoshiba M, Thomson AW. Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol 1994; 98: 71-7.
14. Nagaki M, Iwai H, Naiki T, Ohnishi H, Muto Y, Moriwaki H. High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis. J Infect Dis 2000; 182: 1103-8.
15. Jia HY, Du J, Zhu SH et al. The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C. Hepatobiliary Pancreat Dis Int 2002; 1: 378-82.
16. Zhang W, Yue B, Wang GQ, Lu SL. Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis. Hepatobiliary Pancreat Dis Int 2002; 1: 577-80.
17. Kasprzak A, Zabel M, Biczysko W et al. Expression of cytokines (TNF-α, IL-1α, and IL-2) in chronic hepatitis C: Comparative hybridocytochemical and immunocytochemical study in children and adult patients. J Histochem Cytochem 2004; 52: 29-38.
18. Wang JY, Wang XL, Liu P. Detection of serum TNF-alpha, IFN-beta, IL-6 and IL-8 in patients with hepatitis B. World J Gastroenterol 1999; 5: 38-40.
19. Spahr L, Giostra E, Frossard JL, Bresson-Hadni S, Rubbia-Brandt L, Hadengue A. Soluble TNF-R1, but not tumor necrosis factor alpha, predicts the 3-month mortality in patients with alcoholic hepatitis. J Hepatol 2004; 41: 229-34.
20. Felver ME, Mezey E, McGuire M et al. Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 1990; 14: 255-9.
21. Rodriguez-Rodriguez E, Gonzalez-Reimers E, Santolaria-Fernandez F et al. Cytokine levels in acute alcoholic hepatitis: A sequential study. Drug Alcohol Depend 1995; 39: 23-7.
22. Al-Wabel A, al-Janadi M, Raziuddin S. Cytokine profile of viral and autoimmune chronic active hepatitis-B. J Allergy Clin Immunol 1993; 92: 902-8.
23. Maggiore G, De Benedetti F, Massa M, Pignatti P, Martini A. Circulating levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in children with autoimmune hepatitis. J Pediatr Gastroenterol Nutr 1995; 20: 23-7.
24. Giron-Gonzalez JA, Martinez-Sierra C, Rodriguez-Ramos C et al. Implication of inflammation-related cytokines in the natural history of liver cirrhosis. Liver Int 2004; 24: 437-45.
25. Tilg H, Wilmer A, Vogel W et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992; 103: 264-74.
26. Tilg H, Vogel W, Wiedermann CJ et al. Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease. Hepatology 1993; 18: 1132-8.
27. Lee FY, Lu RH, Tsai YT et al. Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-alpha, and hyperdynamic circulation. Scand J Gastroenterol 1996; 31: 500-5.
28. Eriksson AS, Gretzer C, Wallerstedt S. Elevation of cytokines in peritoneal fluid and blood in patients with liver cirrhosis. Hepatogastroenterology 2004; 51: 505-9.
29. Robak E, Sysa-Jedrzejewska A, Dziankowska B, Torzecka D, Chojnowski K, Robak T. Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity. Arch Immunol Ther Exp (Warsz) 1998; 46: 375-80.
30. Meijer C, Huysen V, Smeenk RT, Swaak AJ. Profiles of cytokines (TNF alpha and IL-6) and acute phase proteins (CRP and alpha 1AG) related to the disease course in patients with systemic lupus erythematosus. Lupus 1993; 2: 359-65.
31. Kane D, Gogarty M, O'leary J et al Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate. Arthritis Rheum 2004; 50: 3286-95.